Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma
Cancer Growth and Metastasis · 2013
DOI: 10.4137/cgm.s11113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Growth and Metastasis, 2013. Verfasst von Stefanie Kewitz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Martin-Luther-University Halle-Wittenberg, University Clinic and Polyclinic for Child and Adolescent Medicine, Halle, Germany. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Curcumin, a phytochemical isolated from curcuma plants which are used as coloring ingredient for the preparation of curry powder, has several activities which suggest that it might be an interesting drug for the treatment or prevention of cancer. Curcumin targets different pathways which are involved in the malignant phenotype of tumor cells, including the nuclear factor kappa B (NFKB) pathway. This pathway is deregulated in multiple tumor entities, including Hodgkin's lymphoma (HL). Indeed, curcumin can inhibit growth of HL cell lines and increases the sensitivity of these cells for cisplatin. In this review we summarize curcumin activities with special focus on possible activities against HL cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Martin-Luther-University Halle-Wittenberg, University Clinic and Polyclinic for Child and Adolescent Medicine, Halle, Germany.
Zitieren
APA
Kewitz, S., Volkmer, I., & Staege, M. S. (2013). Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma. Cancer Growth and Metastasis. https://doi.org/10.4137/cgm.s11113
Vancouver
Kewitz S, Volkmer I, Staege MS. Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma. Cancer Growth and Metastasis. 2013. doi:10.4137/cgm.s11113
BibTeX
@article{Kewitz2013,
author = {Kewitz, Stefanie and Volkmer, Ines and Staege, Martin S},
title = {Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma},
journal = {Cancer Growth and Metastasis},
year = {2013},
doi = {10.4137/cgm.s11113}
}
EUVIMED